Four climbers went up and down Everest in under a week with the help of xenon gas—a record-breaking ascent that has ignited ...

In patients with renal insufficiency associated with increased hemoglobin levels and polycythemia, the possibilities of recombinant erythropoietin overdosing and disorders such as neoplasms and ...

Abstract An additional target for reducing infarct size, namely, attenuation of apoptosis, has recently emerged. Erythropoietin (Epo) exhibits properties that may attenuate this process and enhance ...

Recombinant Erythropoietin for the Treatment of Anemia of Prematurity: Is it Beneficial? Deborah L. Fike, MSN, RNC, NNP Disclosures NAINR. 2004;4 (3) 0 ...

We hypothesized that cord blood erythropoietin (EPO), a marker of fetal hypoxia, relates to gestational factors and not solely those associated with delivery. We investigated the association ...

Bacterial physiology is a scientific discipline that concerns the life-supporting functions and processes of bacteria, which allow bacterial cells to grow and reproduce. Non-photosynthetic ...

Low levels of erythropoietin (EPO), a substance in the blood that stimulates red blood cell production in preterm infants, provide a rationale for the use of EPO to prevent or treat anaemia. A total ...

Mission & scope Frontiers in Physiology explores the physiology of living systems across all levels, from the molecular and subcellular to the intact organism and its interaction with the environment.

Background— Erythropoietin (Epo) receptors (EpoRs) are expressed in the heart. We have recently demonstrated that the endogenous Epo-EpoR system plays an important protective role in myocardial ...

Submission checklist Getting started The submitting and corresponding author (s) must register and log in with Frontiers to be able to follow the review process Ensure that your manuscript fits the ...

HbA1c levels are an unreliable indicator of diabetes control in patients given erythropoietin-stimulating agents or IV iron, research has shown.

A significant increase in the total number of Erythropoietin-receptor antagonist (ERA) AAFs (as well in %AAFs) in both urine and blood samples. WADA Director General Olivier Niggli said: “WADA is ...